Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study

The Oncotype DX Recurrence Score (RS), Prosigna Prediction Analysis of Microarray 50 (PAM50) Risk of Recurrence (ROR), EndoPredict (EP), and Breast Cancer Index (BCI) are used clinically for estimating risk of distant recurrence for patients receiving endocrine therapy. Discordances in estimates occ...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Clin Oncol
Hoofdauteurs: Buus, Richard, Sestak, Ivana, Kronenwett, Ralf, Ferree, Sean, Schnabel, Catherine A., Baehner, Frederick L., Mallon, Elizabeth A., Cuzick, Jack, Dowsett, Mitch
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Clinical Oncology 2021
Onderwerpen:
ORIGINAL REPORTS
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8078458/
https://ncbi.nlm.nih.gov/pubmed/33108242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.00853
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items